【2 grams of dabs】At UK£1.43, Is Hays plc (LON:HAS) Worth Looking At Closely?
Hays plc ( LON:HAS ),2 grams of dabs might not be a large cap stock, but it received a lot of attention from a substantial price increase on the LSE over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. But what if there is still an opportunity to buy? Let’s examine Hays’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. Check out our latest analysis for Hays Is Hays still cheap? Hays appears to be expensive according to my price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Hays’s ratio of 45.59x is above its peer average of 29.95x, which suggests the stock is trading at a higher price compared to the Professional Services industry. But, is there another opportunity to buy low in the future? Given that Hays’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. What kind of growth will Hays generate? earnings-and-revenue-growth Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to more than double over the next couple of years, the future seems bright for Hays. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation. What this means for you: Are you a shareholder? HAS’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe HAS should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed. Are you a potential investor? If you’ve been keeping an eye on HAS for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for HAS, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop. Story continues Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example, we've discovered 4 warning signs that you should run your eye over to get a better picture of Hays. If you are no longer interested in Hays, you can use our free platform to see our list of over 50 other stocks with a high growth potential. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. View comments
相关推荐
-
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
Why Vita Life Sciences Limited (ASX:VLS) Looks Like A Quality Company
-
Senate GOP Adds 2 Women to Powerful Judiciary Committee, Report Says
-
Plunge in oil prices threatens Iraq's postwar recovery
-
5 Video Conferencing Stocks to Ride on Coronavirus Commotion
-
Omarosa Laughs Through 20-Minute Colbert Interview, Doesn’t ‘Regret Trying To Be a Voice of Reason’ (Video)
- 最近发表
-
- Is the Options Market Predicting a Spike in Seagate (STX) Stock?
- Taking A Look At Avidly Oyj’s (HEL:AVIDLY) ROE
- States' Settlement With Career Education Corp. Wipes Out $494M in Student Debt
- January 2019 Issue
- Here is Why Growth Investors Should Buy Brinker International (EAT) Now
- When Is It OK to Pay Fact Witnesses? Florida Justices Weigh In
- BRIEF-Shanghai Phoenix Enterprise Elects Zhou Weizhong As Chairman
- The 5 Best Things to Buy at REI Outdoor Sports Store to Get In (Stylish) Shape for Spring
- Earnings Preview: Novanta (NOVT) Q3 Earnings Expected to Decline
- What Kind Of Shareholder Appears On The NVE Corporation’s (NASDAQ:NVEC) Shareholder Register?
- 随机阅读
-
- Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates
- BRIEF-Guangxi Guidong Electric Power's Unit To Invest In Hydroelectric Power Project In The Philippines
- 5 Top Stocks to Break the 'October Effect' Jinx
- ORM ALERT: Monteverde & Associates PC Announces an Investigation of Owens Realty Mortgage, Inc.
- InvestmentPitch Media Video Discusses Recent eResearch Buy Recommendation on Peak Positioning Technologies, Parent Company of a Group of FinTech Subsidiaries operating in China - Video Available on Investmentpitch.com
- Crocs, Shoe Carnival Surge Higher After Susquehanna Upgrades
- Former Senate Banking Chair: Fed Is Losing ‘Ability to Control Interest Rates’
- Nissan's First US-Market Car Was More British Than Japanese
- Pacific Empire Announces Engagement of OreQuest Consultants as Technical Advisors and the Sale of Shares of Nova Royalty Corp. for Proceeds of Approximately C$644,795
- 2016 Trends in Gold Price
- Geoffrey Starks, Brendan Carr Confirmed to New FCC Terms
- China Caixin Manufacturing PMI Worsens in January
- Manufacturing data helps lift stocks, U.S. dollar bounces
- Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance
- Understated Factors To Consider Before Investing In Reliant Bancorp, Inc. (NASDAQ:RBNC)
- Should You Be Impressed By China Nonferrous Mining Corporation Limited’s (HKG:1258) ROE?
- EMERGING MARKETS-Latam stocks weaken as risk rally pauses
- Don’t Sell SORIL Infra Resources Limited (NSE:SORILINFRA) Before You Read This
- USDOLLAR Eyes 10,200- AUD Remains at Risk on RBA Policy
- Chloé Zhao is 2nd woman to win best director prize at Globes
- 搜索
-
- 友情链接
-
- Notification of Major Holdings
- Asia-Pacific Shares Settle Higher as China Factory Activity Expands Beyond Expectations
- A Sliding Share Price Has Us Looking At Malibu Boats, Inc.'s (NASDAQ:MBUU) P/E Ratio
- Ocean Shipping Services Continue To Deteriorate
- Bull of the Day: Garmin Ltd. (GRMN)
- Camber Energy, Inc. and Viking Energy Group, Inc. Amend Definitive Merger Agreement Relating to Their Planned Combination and Provide Update on Status of Merger
- IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Beyond Meat, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- GOLO Mobile Inc. Retains Market Maker
- Apollo Endosurgery, Inc. Reports First Quarter 2020 Results
- Time To Worry? Analysts Are Downgrading Their Aubay Société Anonyme (EPA:AUB) Outlook